California MD's DEA Registration Revoked for Good
Published Date: 2/7/2025
Notice
Summary
Dr. Massoud Amini from California lost his DEA license to handle controlled substances because he no longer has state permission to do so. He didn’t ask for a hearing to challenge this, so the DEA officially revoked his registration. This means he can’t legally prescribe or manage controlled drugs anymore, effective immediately.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked for Dr. Amini
The DEA revoked Massoud Amini, M.D.'s Certificate of Registration No. BA6612142 because his California medical license was revoked effective January 12, 2024. As of the DEA Order effective March 10, 2025, he may not legally prescribe, dispense, or otherwise handle controlled substances.
Pending Renewal and New Registration Applications Denied
The Order denies any pending applications of Massoud Amini, M.D., to renew or modify DEA Certificate No. BA6612142 and denies any pending application for additional DEA registration in California. This denial is effective March 10, 2025.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-17276, Importer of Controlled Substances Application: Biopharmaceutical Research Company
Biopharmaceutical Research Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
2026-17285, Importer of Controlled Substances Application: Prof Compounding CTS of Ameri
Prof Compounding CTS of Ameri has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
2026-17275, Catina Allen, N.P.; Decision and Order
Catina Allen, a nurse practitioner from Indiana, lost her DEA registration because she no longer has the legal right to handle controlled substances in her state. She didn’t ask for a hearing to challenge this, so the DEA officially revoked her registration, which expired on June 30, 2026. This means she can’t prescribe or manage controlled drugs anymore, affecting her medical practice and patients.
2026-16665, Exempt Chemical Preparations Under the Controlled Substances Act
The applications for exempt chemical preparations received by the Drug Enforcement Administration between March 1, 2026, and June 30, 2026, as listed below, were accepted for filing and have been approved or denied as indicated. This publication addresses preparations through June 30, 2026, that were not included in previous Federal Register notices, and it does not affect preparations that have been previously published.
Previous / Next Documents
Previous: 2025-02341, James T. Craig, D.D.S.; Decision and Order
James T. Craig, a dentist from Colorado, lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. He didn’t ask for a hearing to challenge this, so the DEA officially revoked his registration, which expired in August 2024. This means he can’t prescribe or manage controlled drugs anymore, and the decision is final.
Next: 2025-02346, Foreign-Trade Zone (FTZ) 18, Notification of Proposed Production Activity; Halo Industries, Inc.; (Semiconductor Wafers); Santa Clara, California
Halo Industries in Santa Clara wants to start making semiconductor wafers inside Foreign-Trade Zone 18, which means they can bring in certain materials without paying some import taxes. This move could save the company money and speed up production. People have until March 19, 2025, to share their thoughts before the plan gets the green light.